Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - SELECT MEDICAL HOLDINGS CORP | c05992e8vk.htm |
| EX-3.1 - EXHIBIT 3.1 - SELECT MEDICAL HOLDINGS CORP | c05992exv3w1.htm |
| EX-3.2 - EXHIBIT 3.2 - SELECT MEDICAL HOLDINGS CORP | c05992exv3w2.htm |
| EX-10.2 - EXHIBIT 10.2 - SELECT MEDICAL HOLDINGS CORP | c05992exv10w2.htm |
| EX-10.1 - EXHIBIT 10.1 - SELECT MEDICAL HOLDINGS CORP | c05992exv10w1.htm |
Exhibit 99.1
|
 |
|
FOR IMMEDIATE RELEASE
|
4714 Gettysburg Road Mechanicsburg, PA 17055 |
|
| NYSE Symbol: SEM |
Select Medical Holdings Corporation Announces Appointment
of David S. Chernow as President and Chief Strategy Officer
of David S. Chernow as President and Chief Strategy Officer
MECHANICSBURG, PENNSYLVANIA — September 13, 2010 — Select Medical Holdings Corporation
(NYSE: SEM) today announced the appointment of David S. Chernow as its President and Chief Strategy
Officer. In connection with such appointment, Mr. Chernow has resigned, effective today, from
Select’s Board of Directors.
“Select Medical has grown significantly over the years and will continue to do so,” said
Robert A. Ortenzio, Select’s Chief Executive Officer. “A dual focus is required to drive strategy
for the future, while ensuring that our current operations are effective, efficient and of the
highest quality. We are pleased to have an executive and leader of David’s caliber join Select
Medical as President and Chief Strategy Officer. He will work closely with me and with Patricia A.
Rice, President and Chief Operating Officer, and other members of Select’s senior management team.”
“I welcome the opportunity to join Select’s management team in this dynamic, new leadership
position,” said Mr. Chernow. “Since its inception in 1996, Select has been focused on clinical
quality, operational excellence and progressive yet responsible growth. I look forward to
continuing Select’s tradition of excellence and charting its strategic direction and future
growth.”
Most recently, Mr. Chernow served as President and CEO of Oncure Medical Corp., a national
network of cancer treatment centers. From 2001 to 2007, he was President and CEO of JA Worldwide
(formerly known as Junior Achievement), the world’s largest non-profit organization dedicated to
educating young people about business, economics and free enterprise.
Mr. Chernow co-founded American Oncology Resources in 1992 and served as its Chief Development
Officer until a 1999 merger formed US Oncology. At US Oncology, he was President of its Physician
Services Group. Mr. Chernow is a graduate of the University of California at Los Angeles and
received his law degree (J.D.) from Pepperdine University.
Sean M. Traynor, a General Partner of Welsh Carson Anderson & Stowe, has also resigned,
effective today, from Select’s Board of Directors to permit the Board’s independent Directors to
continue to constitute a majority of the Board. “We wish to recognize and thank Sean Traynor for
his many years of service as a member of Select’s Board of Directors and his invaluable
contributions to the company,” remarked Rocco A. Ortenzio, Select’s Executive Chairman.
Select Medical Holdings Corporation is a leading operator of specialty hospitals in the United
States. As of June 30, 2010, Select operated 89 long term acute care hospitals and 6 acute medical
rehabilitation hospitals in 25 states. Select is also a leading operator of outpatient
rehabilitation clinics in the United States, with approximately 953 locations in 36 states and the
District of Columbia. Select also provides medical rehabilitation services on a contract basis at
nursing homes, hospitals, assisted living and senior care centers, schools and worksites.
Information about Select is available at http://www.selectmedicalholdings.com/
Certain statements contained herein that are not descriptions of historical facts are
“forward-looking” statements (as such term is defined in the Private Securities Litigation Reform
Act of 1995). Because such statements include risks and uncertainties, actual results may differ
materially from those expressed or implied by such forward-looking statements due to factors
including but not limited to those described in Select’s filings with the Securities and Exchange
Commission.
Investor inquiries:
Joel T. Veit
Vice President & Treasurer
717/972-1100
ir@selectmedicalcorp.com
Vice President & Treasurer
717/972-1100
ir@selectmedicalcorp.com
Media inquiries:
Carolyn N. Curnane
Vice President, Corporate Communications
610 - 992-7176
ccurnane@selectmedicalcorp.com
Vice President, Corporate Communications
610 - 992-7176
ccurnane@selectmedicalcorp.com
SOURCE: Select Medical Holdings Corporation